Home LiteratureArticle Details
PMID: 6387982 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. Review

Structure and function of the anaphylatoxins.

Springer seminars in immunopathology ·Vol. 7 ·No. 2-3 ·1984-00-00 ·Pages 193-219

Hugli TE

Abstract

Chemical and physical characterization of the anaphylatoxin molecules have provided a reasonably clear description of the architecture of these bioactive proteins. The primary structures of C3a, C4a, and C5a from man and from a number of animal species have been elucidated, and it is apparent that the three anaphylatoxins are genetically related. The anaphylatoxin protein chains very in length from 74 to 78 residues and no fewer than 30% of the residues are homologous when comparing C3a, C4a, and C5a within or between species. Synthetic peptide studies have been instrumental in identifying molecular features essential for the function of anaphylatoxins. Information gleaned from the structure-function studies with synthetic analogue peptides of the anaphylatoxins define putative "active sites" in these effector molecules. Linear sequences at the carboxy-terminus of C3a and C4a fulfill all of the criteria of an "active site," in that synthetic peptides of an identical sequence can mimic the biologic actions of the natural factors. In the case of human C3a, a crystallographic analysis has been performed and a three-dimensional structure was elucidated at the 3.2 A level. The crystalline structure of C3a provides valuable new information regarding the alpha helical regions and identifies the arrangement of intra-chain disulfide linkages. Taken together, the structural data now accumulated for anaphylatoxins permit molecular modelling of these proteins, designates favored conformational arrangements of the native structures, and specifically localizes the effector sites. Furthermore, elements at the essential active site have been defined with such precision that models are proposed detailing the exact nature of ligand interactions between anaphylatoxins and specific cellular receptors. Biologic characterization of the anaphylatoxins continues at a rapid pace and each advance provides a clearer view of the role of these humoral mediators in host defense. A variety of responses to anaphylatoxins are known to occur at the cellular level and are mediated in a hormone-like fashion. Diversity of action for these factors at the tissue level is readily explained by the numerous cell types stimulated by the anaphylatoxins. Cellular responses to the anaphylatoxins are perhaps the most easily defined and studied; however, tissue and systemic effects more accurately reflect the physiologic role of anaphylatoxins. Considerable progress has been made in understanding the mechanisms whereby anaphylatoxins mediate two major tissue effects, namely enhancement of vascular permeability and induction of smooth muscle contraction.(ABSTRACT TRUNCATED AT 400 WORDS)

MeSH Terms
Amino Acid Sequence Anaphylatoxins/pharmacology,physiology Animals Binding Sites Capillary Permeability Complement C3/physiology Complement C3a Complement C4/physiology Complement C4a Complement C5/physiology Complement C5a Humans Lung/drug effects Lung Diseases/etiology Models, Chemical Peptides/physiology Protein Conformation
Chemicals
Anaphylatoxins Complement C3 Complement C4 Complement C5 Peptides Complement C3a Complement C4a Complement C5a
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Hugli T E
References (78)
78 references, click to expand
  1. Lung injury induced by leukocytic proteases.
    Am J Pathol. 1979 Oct;97(1):111-36 PMID: 495691
  2. Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B.
    J Immunol. 1978 Sep;121(3):851-5 PMID: 211165
  3. Human C5a-related synthetic peptides as neutrophil chemotactic factors.
    Biochem Biophys Res Commun. 1979 Jan 30;86(2):227-34 PMID: 426784
  4. Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.
    N Engl J Med. 1980 Apr 3;302(14):789-94 PMID: 6986559
  5. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.
    J Immunol. 1978 Jan;120(1):109-15 PMID: 342601
  6. C3 leukotactic factors produced by a tissue protease.
    J Exp Med. 1969 Sep 1;130(3):505-18 PMID: 4185247
  7. Chemotoxis of mononuclear cells.
    J Exp Med. 1968 Nov 1;128(5):1201-21 PMID: 5682943
  8. Immune complex injury of the lung. Symposium held at the 74th annual meeting of the American Thoracic Society, Las Vegas, Nevada, May 1979.
    Am Rev Respir Dis. 1981 Dec;124(6):738-55 PMID: 6459046
  9. Crystal structure analysis and molecular model of human C3a anaphylatoxin.
    Hoppe Seylers Z Physiol Chem. 1980 Sep;361(9):1389-99 PMID: 7439885
  10. A modified method for chemotaxis under agarose.
    J Immunol Methods. 1979;25(4):337-53 PMID: 372445
  11. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    J Exp Med. 1968 Feb 1;127(2):371-86 PMID: 4383923
  12. The active site of human C4a anaphylatoxin.
    Mol Immunol. 1983 Jun;20(6):637-45 PMID: 6603573
  13. Amino acid sequences of mouse complement C3 derived from nucleotide sequences of cloned cDNA.
    Ann N Y Acad Sci. 1983;421:307-12 PMID: 6609661
  14. Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.
    Biochem J. 1982 Nov 1;207(2):253-60 PMID: 6760852
  15. The primary structure of porcine C3a anaphylatoxin.
    J Immunol. 1976 Sep;117(3):990-5 PMID: 956663
  16. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.
    J Exp Med. 1973 May 1;137(5):1109-23 PMID: 4121926
  17. Acute inflammatory pulmonary reactions induced by chemotactic factors.
    Am J Pathol. 1979 Jul;96(1):71-83 PMID: 464027
  18. [Effect of anaphylatoxin (AT) upon capillary permeability in guinea pig skin].
    Naunyn Schmiedebergs Arch Pharmakol. 1970;266(3):255-60 PMID: 4193283
  19. A chemotactic factor for mononuclear leukocytes.
    Proc Soc Exp Biol Med. 1971 Nov;138(2):387-90 PMID: 5118450
  20. Enhanced vascular permeability and haemorrhage-inducing activity of rabbit C5ades arg: probable role of polymorphonuclear leucocyte lysosomes.
    Clin Exp Immunol. 1980 Sep;41(3):512-20 PMID: 7438564
  21. Human C5a des Arg increases vascular permeability.
    J Immunol. 1981 Dec;127(6):2376-80 PMID: 6170701
  22. Complement fragments, alveolar macrophages, and alveolitis.
    Am J Pathol. 1979 Oct;97(1):93-110 PMID: 495697
  23. C3a-induced contraction of guinea pig lung parenchyma: role of cyclooxygenase metabolites.
    Immunopharmacology. 1983 Feb;5(3):251-7 PMID: 6403485
  24. Activation, activities and pharmacologically active products of complement.
    Pharmacol Rev. 1974 Jun;26(2):125-69 PMID: 4609350
  25. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation.
    Proc Natl Acad Sci U S A. 1983 Dec;80(23):7200-4 PMID: 6417666
  26. Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide.
    J Biol Chem. 1984 Jun 25;259(12):7367-70 PMID: 6610676
  27. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.
    J Clin Invest. 1970 Dec;49(12):2427-36 PMID: 4098172
  28. Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.
    J Clin Invest. 1974 Feb;53(2):591-9 PMID: 11344574
  29. Human plasma carboxypeptidase N. Isolation and characterization.
    J Biol Chem. 1978 Jun 10;253(11):3907-12 PMID: 148463
  30. Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes.
    Am J Pathol. 1978 Mar;90(3):537-50 PMID: 564610
  31. Purification, characterization, and amino acid sequence of rat anaphylatoxin (C3a).
    Biochemistry. 1978 Nov 14;17(23):5031-8 PMID: 309768
  32. Structure and expression of the C3 gene.
    Springer Semin Immunopathol. 1983;6(2-3):119-47 PMID: 6356427
  33. Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.
    Fed Proc. 1982 Dec;41(14):3099-103 PMID: 6216123
  34. A neutrophil chemotactic factor from human C'5.
    J Immunol. 1969 Jan;102(1):93-9 PMID: 5765461
  35. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
    J Biol Chem. 1978 Oct 10;253(19):6955-64 PMID: 690134
  36. The active site of C3a anaphylatoxin.
    J Biol Chem. 1980 Nov 25;255(22):10758-63 PMID: 6968751
  37. Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity.
    J Immunol. 1981 Nov;127(5):1978-82 PMID: 7299121
  38. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    J Clin Invest. 1979 Sep;64(3):804-11 PMID: 89118
  39. Role of the N-terminal regions of hog C3a, C5a and C5a-desArg in their biological activities.
    Mol Immunol. 1986 Apr;23(4):433-40 PMID: 3487713
  40. Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes.
    Inflammation. 1982 Jun;6(2):189-200 PMID: 6179872
  41. Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man.
    Am J Pathol. 1970 Oct;61(1):13-23 PMID: 4099033
  42. Purification and crystallization of human anaphylatoxin, C3a.
    Hoppe Seylers Z Physiol Chem. 1980;361(6):977-80 PMID: 7399418
  43. Humoral mediators of chemotaxis of mononuclear leukocytes.
    J Infect Dis. 1972 Jun;125(6):595-602 PMID: 5037013
  44. Release of histamine from rat mast cells by the complement peptides C3a and C5a.
    Immunology. 1975 Jun;28(6):1067-80 PMID: 48505
  45. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
    Biochemistry. 1984 Feb 14;23(4):585-9 PMID: 6608957
  46. Cutaneous responses to human C 3 anaphylatoxin in man.
    Clin Exp Immunol. 1972 May;11(1):13-20 PMID: 4114148
  47. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a).
    Immunology. 1973 Jun;24(6):969-76 PMID: 4123965
  48. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.
    Clin Exp Immunol. 1970 Nov;7(5):723-37 PMID: 4992784
  49. Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified complement fragments C5a and C5a des-arg.
    J Immunol. 1979 Dec;123(6):2511-7 PMID: 574148
  50. Anaphylatoxins: C3a and C5a.
    Adv Immunol. 1978;26:1-53 PMID: 358800
  51. Molecular aspects of the serum chemotactic factors.
    J Reticuloendothel Soc. 1979 Dec;26(Suppl):711-8 PMID: 522086
  52. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Am J Pathol. 1980 Aug;100(2):327-48 PMID: 6967702
  53. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Proc Natl Acad Sci U S A. 1977 May;74(5):1826-30 PMID: 266705
  54. Amino acid sequence of the anaphylatoxin from the fifth component of porcine complement.
    J Biol Chem. 1980 May 25;255(10):4710-5 PMID: 7372604
  55. C5a induced tracheal contraction: a histamine independent mechanism.
    J Immunol. 1980 Jun;124(6):2876-8 PMID: 7373054
  56. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
    J Clin Invest. 1977 Jul;60(1):260-4 PMID: 874088
  57. Characterization of human C4a anaphylatoxin.
    J Biol Chem. 1981 Mar 25;256(6):2707-11 PMID: 6970745
  58. A plasmin-split fragment of C'3 as a new chemotactic factor.
    J Exp Med. 1967 Aug 1;126(2):189-206 PMID: 4226271
  59. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
    J Immunol. 1982 May;128(5):2247-52 PMID: 6174625
  60. Chemistry and biology of the anaphylatoxin related serum peptide system. I. Purification, crystallization and properties of classical anaphylatoxin from rat serum.
    Eur J Immunol. 1972 Feb;2(1):73-83 PMID: 5082613
  61. Prediction of protein conformation.
    Biochemistry. 1974 Jan 15;13(2):222-45 PMID: 4358940
  62. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.
    J Immunol. 1976 Nov;117(5 Pt 1):1688-94 PMID: 1002996
  63. Circular dichroism of C3a anaphylatoxin. Effects of pH, heat, guanidinium chloride, and mercaptoethanol on conformation and function.
    J Biol Chem. 1975 Feb 25;250(4):1479-83 PMID: 234458
  64. Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
    J Biol Chem. 1975 Nov 10;250(21):8293-301 PMID: 1238393
  65. Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor.
    J Immunol. 1976 Jul;117(1):246-52 PMID: 932427
  66. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement.
    Science. 1968 Oct 18;162(3851):361-3 PMID: 4175690
  67. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
    Crit Rev Immunol. 1981 Feb;1(4):321-66 PMID: 7037298
  68. N-formylmethionyl peptides as chemoattractants for leucocytes.
    Proc Natl Acad Sci U S A. 1975 Mar;72(3):1059-62 PMID: 1093163
  69. Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis.
    J Immunol. 1975 Jan;114(1 Pt 2):516-8 PMID: 1090664
  70. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.
    Proc Natl Acad Sci U S A. 1978 Aug;75(8):3943-7 PMID: 279010
  71. Role of cell surface contact in the kinetics of superoxide production by granulocytes.
    J Clin Invest. 1983 Jul;72(1):113-21 PMID: 6308042
  72. Complete primary structure of human C4a anaphylatoxin.
    J Biol Chem. 1981 Aug 25;256(16):8685-92 PMID: 6167582
  73. Immune complex injury of the lung.
    Am J Pathol. 1979 Oct;97(1):85-92 PMID: 158982
  74. Human C5a and C5a analogs as probes of the neutrophil C5a receptor.
    Mol Immunol. 1980 Feb;17(2):151-61 PMID: 6248769
  75. Anaphylatoxin-mediated contraction of guinea pig lung strips: a nonhistamine tissue response.
    J Immunol. 1981 Jun;126(6):2258-61 PMID: 6164725
  76. Complement anaphylatoxin C5a stimulates release of SRS-A-like activity from guinea-pig lung fragments.
    J Pharm Pharmacol. 1980 Nov;32(11):804 PMID: 6110740
  77. Regulation of immune response by components of the complement cascade and their activated fragments.
    Springer Semin Immunopathol. 1983;6(2-3):173-94 PMID: 6356429
  78. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
    Am J Pathol. 1983 Jul;112(1):48-60 PMID: 6859228
Article Info
Journal
Springer seminars in immunopathology
Abbr.
Springer Semin Immunopathol
ISSN
0344-4325
Published
1984-00-00
Pages
193-219
Language
English
Region
Germany
NLM ID
7910384
Subset
IM
Grants
NIAID NIH HHS · AI 17354 · United States
NHLBI NIH HHS · HL 16411 · United States
NHLBI NIH HHS · HL 25658 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]